Lang Wu to Leukoplakia, Oral
This is a "connection" page, showing publications Lang Wu has written about Leukoplakia, Oral.
Connection Strength
1.524
-
Liu W, Yao Y, Shi L, Tang G, Wu L. A novel lncRNA LOLA1 may predict malignant progression and promote migration, invasion, and EMT of oral leukoplakia via the AKT/GSK-3? pathway. J Cell Biochem. 2021 10; 122(10):1302-1312.
Score: 0.785
-
Liu W, Zhu L, Xu L, Wu L. Exophytic verrucous hyperplasia as a clinical terminology includes verrucous hyperplasia with or without epithelial dysplasia in histology. Oral Oncol. 2021 11; 122:105571.
Score: 0.202
-
Yao Y, Shi L, Wang Y, Shen X, Ye S, Tang G, Wu L. Ablative fractional laser-assisted photodynamic therapy vs. ablative fractional laser for oral leukoplakia treatment: A randomized, controlled pilot study. Photodiagnosis Photodyn Ther. 2021 Dec; 36:102523.
Score: 0.201
-
Yao Y, Shen X, Shi L, Tang G, Wu L. The combination of photodynamic therapy and fractional CO2 laser for oral leukoplakia: Case series. Photodiagnosis Photodyn Ther. 2020 Mar; 29:101597.
Score: 0.177
-
Liu W, Wu L, Shen XM, Shi LJ, Zhang CP, Xu LQ, Zhou ZT. Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia. Int J Cancer. 2013 Feb 15; 132(4):868-74.
Score: 0.107
-
Yao YL, Wang YF, Li CX, Wu L, Tang GY. Management of oral leukoplakia by ablative fractional laser-assisted photodynamic therapy: A 3-year retrospective study of 48 patients. Lasers Surg Med. 2022 07; 54(5):682-687.
Score: 0.052